These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 23713981)
1. Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids. Andrag E; Curtis MJ Br J Pharmacol; 2013 Aug; 169(8):1840-8. PubMed ID: 23713981 [TBL] [Abstract][Full Text] [Related]
2. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Underdown NJ; Hiley CR; Ford WR Br J Pharmacol; 2005 Nov; 146(6):809-16. PubMed ID: 16158067 [TBL] [Abstract][Full Text] [Related]
3. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system. Romero TR; Resende LC; Guzzo LS; Duarte ID Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980 [TBL] [Abstract][Full Text] [Related]
4. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. Wagner JA; Abesser M; Harvey-White J; Ertl G J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503 [TBL] [Abstract][Full Text] [Related]
5. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors. Silva GB; Atchison DK; Juncos LI; García NH Am J Physiol Renal Physiol; 2013 Feb; 304(4):F376-81. PubMed ID: 23220721 [TBL] [Abstract][Full Text] [Related]
6. Opposing roles of CB Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419 [TBL] [Abstract][Full Text] [Related]
7. Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats. Marichal-Cancino BA; Altamirano-Espinoza AH; Manrique-Maldonado G; MaassenVanDenBrink A; Villalón CM Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):240-7. PubMed ID: 24118786 [TBL] [Abstract][Full Text] [Related]
8. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS. González C; Herradón E; Abalo R; Vera G; Pérez-Nievas BG; Leza JC; Martín MI; López-Miranda V Diabetes Metab Res Rev; 2011 May; 27(4):331-40. PubMed ID: 21309057 [TBL] [Abstract][Full Text] [Related]
9. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors. Romero TR; Pacheco Dda F; Duarte ID Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446 [TBL] [Abstract][Full Text] [Related]
10. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes. Al Kury LT; Voitychuk OI; Ali RM; Galadari S; Yang KH; Howarth FC; Shuba YM; Oz M Cell Calcium; 2014 Feb; 55(2):104-18. PubMed ID: 24472666 [TBL] [Abstract][Full Text] [Related]
11. Activation of CB Karpińska O; Baranowska-Kuczko M; Kloza M; Ambroz Ewicz E; Kozłowski T; Kasacka I; Malinowska B; Kozłowska H Am J Physiol Regul Integr Comp Physiol; 2017 Jun; 312(6):R883-R893. PubMed ID: 28356298 [TBL] [Abstract][Full Text] [Related]
12. Anandamide enhances expression of heat shock protein 72 to protect against ischemia-reperfusion injury in rat heart. Li Q; Shi M; Li B J Physiol Sci; 2013 Jan; 63(1):47-53. PubMed ID: 23007622 [TBL] [Abstract][Full Text] [Related]
13. Anandamide reduces intracellular Ca2+ concentration through suppression of Na+/Ca2+ exchanger current in rat cardiac myocytes. Li Q; Cui N; Du Y; Ma H; Zhang Y PLoS One; 2013; 8(5):e63386. PubMed ID: 23667607 [TBL] [Abstract][Full Text] [Related]
14. Protective role of endocannabinoid signaling in an animal model of haloperidol-induced tardive dyskinesia. Röpke J; Ferreira-Vieira TH; Iglesias LP; Asth L; Ribeiro FM; Moreira FA Pharmacol Biochem Behav; 2021 Jul; 206():173193. PubMed ID: 33933537 [TBL] [Abstract][Full Text] [Related]
15. Why do cannabinoid receptors have more than one endogenous ligand? Di Marzo V; De Petrocellis L Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3216-28. PubMed ID: 23108541 [TBL] [Abstract][Full Text] [Related]
16. The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation. Clements-Jewery H; Hearse DJ; Curtis MJ Br J Pharmacol; 2002 Dec; 137(7):1089-99. PubMed ID: 12429582 [TBL] [Abstract][Full Text] [Related]
17. Protection by cimetidine, but not ranitidine, implies that H2 receptors do not mediate arrhythmogenesis in a rat model of regional ischaemia and reperfusion in vitro. Banning MM; Curtis MJ Cardiovasc Res; 1995 Nov; 30(5):705-10. PubMed ID: 8595616 [TBL] [Abstract][Full Text] [Related]
18. Protection against ventricular fibrillation by the PAF antagonist, BN-50739, involves an ischaemia-selective mechanism. Baker KE; Curtis MJ J Cardiovasc Pharmacol; 1999 Sep; 34(3):394-401. PubMed ID: 10470998 [TBL] [Abstract][Full Text] [Related]
19. Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia-reperfusion-induced ventricular arrhythmias. Ng FS; Shadi IT; Peters NS; Lyon AR J Mol Cell Cardiol; 2013 Jun; 59():67-75. PubMed ID: 23402927 [TBL] [Abstract][Full Text] [Related]
20. Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes. Lu Y; Akinwumi BC; Shao Z; Anderson HD J Cardiovasc Pharmacol; 2014 Nov; 64(5):420-30. PubMed ID: 24979612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]